Notice is hereby given that the adjourned Annual Meeting of shareholders of AFT Pharmaceuticals Limited (AFT or the Company) will be convened and held on a fully virtual basis on Tuesday, 8 September 2020 commencing at 10.30am (New Zealand time) to transact the business set out in the Notice of Annual Meeting of Shareholders 2020 dated 15 July 2020 (Original AGM Notice).
The Original AGM Notice was sent to shareholders on 15 July 2020 and is available on the Company’s website (https://investors.aftpharm.com/Investors/?page=Meetings) and the NZX website (https://www.nzx.com/announcements/356233).
Shareholders can participate in the Annual Meeting virtually through the web platform web.lumiagm.com, or by downloading the Lumi AGM app, and entering the meeting ID 323-946-452. To participate, shareholders will need their CSN/Securityholder number which can be found on their proxy form which accompanied the Original AGM Notice. Shareholders will be able to view presentations, ask questions and cast their vote from their own computers, mobiles or similar devices. Participants who are not shareholders will be able to log in as guests.
Further step by step details are set out in the attached Virtual Meeting Guide. If shareholders have any questions, or need assistance with the online process, please contact Computershare on +64 9 488 8777 between 8.30am 5.00pm (New Zealand time), Monday to Friday.
Proxy forms submitted before 10.30am (New Zealand time) Monday, 10 August 2020 (Proxy Deadline) remain valid for the adjourned Annual Meeting. The Company is not able to accept proxy forms submitted after the Proxy Deadline. If you submitted a proxy form before the Proxy Deadline and now wish to withdraw it, please contact the Company at investor.relations@aftpharm.com or Computershare on +64 9 488 8777 before 10.30am (New Zealand time) on Tuesday, 8 September 2020.
AFT would like to thank all shareholders for their patience and co-operation in enabling us to hold our adjourned Annual Meeting via virtual means amidst the current COVID-19 pandemic.
By Order of the AFT Pharmaceuticals Limited Board
David Flacks Chairman
21 August 2020
